AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Vaxcyte, Inc. Director's Dealing 2023

Nov 29, 2023

31100_dirs_2023-11-29_55e4ef71-3a3a-43c6-ab74-5de6f840e57f.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2023-11-27

Reporting Person: Lee Jacks (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities owned.	0	Direct